Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-24 · accession 0001213900-25-007530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-28 | 2025-01-24 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +23.5K | 45.5K | +107% | $0 |
| D | 2025-01-28 | 2025-01-24 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-24 | A | A | 23,500 | $0.00 | 45,500 | D | — | — | (F1) The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-24 | A | A | 140,000 | $0.00 | 140,000 | D | $4.53 · — to 2035-01-23 | 140,000 Common Stock | (F2) 25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. |